Old Web
English
Sign In
Acemap
>
authorDetail
>
Tessa L. Holyoake
Tessa L. Holyoake
University of Strathclyde
Medicine
Cancer research
Imatinib
Progenitor cell
Biology
4
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
survival and enhances their proliferation production supports CML stem and progenitor cell α Autocrine TNF
2014
Mhairi Copland
Heather G. Jørgensen
Tessa L. Holyoake
Paolo Gallipoli
Francesca Pellicano
Heather Morrison
Kamilla M.E. Laidlaw
Elaine K. Allan
Ravi Bhatia
Show All
Source
Cite
Save
Citations (1)
inhibitors stem and progenitor cells and synergizes with tyrosine kinase BMS-214662 potently induces apoptosis of chronic myeloid leukemia
2013
Roberto Weinmann
Tessa L. Holyoake
Mhairi Copland
Francesca Pellicano
Linda Richmond
Elaine K. Allan
Ashley Hamilton
Show All
Source
Cite
Save
Citations (1)
imatinib in primary CML, but does not eliminate the quiescent fraction Dasatinib (BMS-354825) targets an earlier progenitor population than
2013
Joanne C. Mountford
Tessa L. Holyoake
Mhairi Copland
Ashley Hamilton
Lucy J. Elrick
Janet W. Baird
Elaine K. Allan
Show All
Source
Cite
Save
Citations (0)
Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro
2004
Blood
Heather G. Jørgensen
Elaine K. Allan
Joanne C. Mountford
Linda Richmond
Moira A. Elliott
Tessa L. Holyoake
Show All
Source
Cite
Save
Citations (2)
1